PLAN OF DISTRIBUTION
We or any selling shareholder may sell or distribute our securities included in this prospectus through underwriters, through agents, to
dealers, in private transactions, at market prices prevailing at the time of sale, at prices related to the prevailing market prices, or at negotiated prices, or otherwise.
In addition, we or the selling shareholders may sell some or all of our securities included in this prospectus through:
|
|
|
a block trade in which a broker-dealer may resell a portion of the block, as principal, in order to facilitate
the transaction; |
|
|
|
a distribution by way of dividend or otherwise to our existing shareholders; |
|
|
|
purchases by a broker-dealer, as principal, and resale by the broker-dealer for its account;
|
|
|
|
ordinary brokerage transactions and transactions in which a broker-dealer solicits purchasers; or
|
|
|
|
trading plans entered into by us pursuant to Rule 10b5-1 under the
Securities Exchange Act of 1934, as amended, or the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of our securities on the basis
of parameters described in such trading plans. |
In addition, we or the selling shareholders may enter into options or
other types of transactions that require us or them to deliver our securities to a broker-dealer, who will then resell or transfer the securities under this prospectus. We or any selling shareholder may enter into hedging transactions with respect
to our securities. For example, we or any selling shareholder may:
|
|
|
enter into transactions involving short sales of our common shares by broker-dealers; |
|
|
|
sell common shares short and deliver the shares to close out short positions; |
|
|
|
enter into options or other types of transactions that require us or them to deliver common shares to a
broker-dealer, who will then resell or transfer the common shares under this prospectus; or |
|
|
|
loan or pledge the common shares to a broker-dealer, who may sell the loaned shares or, in the event of default,
sell the pledged shares. |
We or any selling shareholder may enter into derivative transactions with third parties, or
sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this
prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us, any selling shareholder or borrowed from us or any selling shareholder or others to settle those
sales or to close out any related open borrowings of stock, and may use securities received from us or any selling shareholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale
transactions may be an underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, we or any selling shareholder may otherwise loan or pledge
securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or
in connection with a concurrent offering of other securities.
The selling shareholders and any broker-dealers or other persons acting on
our behalf or on the behalf of the selling shareholders that participate with us or the selling shareholders in the distribution of the securities may be deemed to be underwriters and any commissions received or profit realized by them on the resale
of the securities may be deemed to be underwriting discounts and commissions under the U.S. Securities Act of 1933, as amended, or the Securities Act. As a result, we have or will inform the selling shareholders that Regulation M, promulgated under
the Exchange Act, may apply to sales by the selling shareholders in the market. The selling shareholders may agree to indemnify any broker, dealer or agent that participates in transactions involving the sale of our common shares against certain
liabilities, including liabilities arising under the Securities Act.
As of the date of this prospectus, we are not a party to any
agreement, arrangement or understanding between any broker or dealer and us with respect to the offer or sale of the securities pursuant to this prospectus.
At the time that any particular offering of securities is made, to the extent required by the Securities Act, a prospectus or prospectus
supplement, or if appropriate, a post-effective amendment, will be distributed, setting forth the terms of the offering, including the aggregate number of securities being offered, the purchase price of the securities, the public offering price of
the securities, the names of any underwriters, dealers or agents, any discounts, commissions and other items constituting compensation from us, and any discounts, commissions or concessions allowed or
re-allowed or paid to dealers. Furthermore, we, our executive officers, our directors and the selling shareholders may agree, subject to certain exemptions, that for a certain period from the date of the
prospectus supplement under which the securities are offered, we and they will not, without the prior written consent of an underwriter, offer, sell, contract to sell, pledge or otherwise dispose of any of our common shares or any securities
convertible into or exchangeable for common shares. However, an underwriter, in its sole discretion, may release any of the securities subject to these lock-up agreements at any time without notice. We expect
an underwriter to exclude from these lock-up agreements securities exercised and/or sold pursuant to trading plans entered into by any selling shareholder pursuant to Rule
10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of the selling
shareholders securities on the basis of parameters described in such trading plans.
Underwriters or agents could make sales in
privately negotiated transactions and/or any other method permitted by law, including sales deemed to be an at-the-market offering as defined in Rule 415 promulgated
under the Securities Act, which includes sales made directly on or through the NYSE, the existing trading market for our common shares, or sales made to or through a market maker other than on an exchange.
We will bear the costs relating to all of the securities offered and sold by us under this registration statement.
7